{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-240882","form_type":"8-K","ticker":"ENOV","cik":"0001420800","company_name":"Enovis CORP","filed_at":"2023-09-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.875630+00:00","generated_at":"2026-06-10T09:11:03.579990+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Enovis to acquire LimaCorporate for €800M enterprise value","bullets":["Enterprise value €800M: €700M cash at closing + €100M in Enovis common shares within 18 months.","Expected 2024 revenue $290-300M and adjusted EBITDA $70-75M from Lima.","Approximately $40M in cost synergies targeted by year three post-close via supply chain and cost consolidation.","Transaction expected to close early 2024, subject to regulatory approvals; neutral to slightly accretive to 2024 adjusted EPS.","Deal creates ~$1B revenue reconstruction business with ~50% in fast-growing extremities markets."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-240882","json":"https://secwatch.observer/filing/0001193125-23-240882.json","markdown":"https://secwatch.observer/filing/0001193125-23-240882.md","text":"https://secwatch.observer/filing/0001193125-23-240882.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420800/000119312523240882/0001193125-23-240882-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420800/000119312523240882/d542911d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T09:11:03.579990+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}